CFD 属于复杂的高风险金融工具,其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作,以及是否能够接受高额亏损的风险。

Scan to Download iOS&Android APP

交易 Kymera Therapeutics, Inc. - KYMR CFD

30.00
2.31%
  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 0.11
多头隔夜费

Long position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.024068%
空头隔夜费

Short position overnight fee


Margin. Your investment $1,000.00
隔夜费用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
0.001846%
隔夜费时间 21:00 (UTC)
最小交易量 1
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

关键数据
前收盘价* 30.71
开盘价* 30.84
1 年变化* -28.45%
日范围* 30 - 30.92
52 周范围 13.15-44.75
平均交易量(10 天) 455.69K
平均交易量(3 个月) 11.39M
市值 1.71B
市盈率 -100.00K
流通股 55.18M
收入 46.83M
EPS -2.88
股息(收益率 %) N/A
贝塔 -100.00K
下一个财报发布日期 May 1, 2023

所有数据都是由Refinitiv提供的, 除了标有星号的数据, 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平倉 Change Change (%) 開倉 High Low
Mar 20, 2023 30.71 0.74 2.47% 29.97 31.00 29.76
Mar 17, 2023 30.98 0.89 2.96% 30.09 31.25 29.60
Mar 16, 2023 31.01 0.35 1.14% 30.66 31.59 29.77
Mar 15, 2023 31.10 0.26 0.84% 30.84 31.52 29.93
Mar 14, 2023 31.57 -0.59 -1.83% 32.16 33.08 30.85
Mar 13, 2023 31.15 2.50 8.73% 28.65 31.37 28.65
Mar 10, 2023 29.56 -1.41 -4.55% 30.97 31.26 28.44
Mar 9, 2023 31.66 -0.36 -1.12% 32.02 33.39 31.30
Mar 8, 2023 33.10 1.08 3.37% 32.02 33.15 32.02
Mar 7, 2023 32.85 0.33 1.01% 32.52 33.66 32.11
Mar 6, 2023 32.58 0.11 0.34% 32.47 32.85 31.47
Mar 3, 2023 32.76 0.21 0.65% 32.55 32.90 31.88
Mar 2, 2023 32.41 0.77 2.43% 31.64 32.69 30.12
Mar 1, 2023 32.04 0.62 1.97% 31.42 32.12 30.83
Feb 28, 2023 31.37 -0.48 -1.51% 31.85 33.04 31.03
Feb 27, 2023 31.90 -0.03 -0.09% 31.93 32.39 30.94
Feb 24, 2023 31.43 0.53 1.72% 30.90 32.95 30.90
Feb 23, 2023 33.12 0.10 0.30% 33.02 33.67 31.40
Feb 22, 2023 31.48 1.01 3.31% 30.47 31.92 30.44
Feb 21, 2023 30.71 -2.15 -6.54% 32.86 33.07 30.43

Kymera Therapeutics, Inc. Events

時間(協調世界時) (UTC) 國家 事件
No events scheduled
查看所有活動
  • 年度
  • 每季度
2021 2020 2019 2018
总收入 72.832 34.034 2.934 0
收入 72.832 34.034 2.934 0
总营业费用 173.362 80.338 45.139 21.451
销售/一般/行政费用,总计 36.345 18.233 7.981 3.772
研究与开发 137.017 62.105 37.158 17.679
营业收入 -100.53 -46.304 -42.205 -21.451
利息收入(费用),非经营净值 0.313 0.711 0.959 -0.016
税前净收入 -100.217 -45.593 -41.246 -21.467
税后净收入 -100.217 -45.593 -41.246 -21.467
未计算非常项目前的净收益 -100.217 -45.593 -41.246 -21.467
净收入 -100.217 -45.593 -41.246 -21.467
普通股股东可获收益 (不含非经常性项目) -100.217 -54.643 -41.246 -21.467
普通股股东可获收益 (含非經常性項目) -100.217 -54.643 -41.246 -21.467
摊薄净收入 -100.217 -54.643 -41.246 -21.467
摊薄后加权平均股 47.989 44.4822 43.1386 43.1386
扣除特别项目的每股摊薄盈利 -2.08833 -1.22842 -0.95613 -0.49763
Dividends per Share - Common Stock Primary Issue 0 0 0
每股正常摊薄盈利 -2.08833 -1.22842 -0.95613 -0.49763
Total Adjustments to Net Income 0 -9.05
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
总收入 9.622 15.275 20.336 18.519 18.702
收入 9.622 15.275 20.336 18.519 18.702
总营业费用 46.555 49.269 48.973 43.249 31.871
销售/一般/行政费用,总计 10.611 11.74 10.667 8.029 5.909
研究与开发 35.944 37.529 38.306 35.22 25.962
营业收入 -36.933 -33.994 -28.637 -24.73 -13.169
利息收入(费用),非经营净值 0.249 0.094 0.055 0.07 0.094
税前净收入 -36.684 -33.9 -28.582 -24.66 -13.075
税后净收入 -36.684 -33.9 -28.582 -24.66 -13.075
未计算非常项目前的净收益 -36.684 -33.9 -28.582 -24.66 -13.075
净收入 -36.684 -33.9 -28.582 -24.66 -13.075
Total Adjustments to Net Income 0 0 0 0
普通股股东可获收益 (不含非经常性项目) -36.684 -33.9 -28.582 -24.66 -13.075
普通股股东可获收益 (含非經常性項目) -36.684 -33.9 -28.582 -24.66 -13.075
摊薄净收入 -36.684 -33.9 -28.582 -24.66 -13.075
摊薄后加权平均股 51.6511 51.4312 50.7149 45.0942 44.6496
扣除特别项目的每股摊薄盈利 -0.71023 -0.65913 -0.56358 -0.54685 -0.29284
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常摊薄盈利 -0.71023 -0.65913 -0.56358 -0.54685 -0.29284
  • 年度
  • 每季度
2021 2020 2019 2018
流动资产总额 451.273 302.339 92.845 41.79
现金和短期投资 442.418 296.202 91.957 41.26
现金等价物 47.976 31.004 76.015 41.26
短期投资 394.442 265.198 15.942 0
应收账款总额,净额 0.135 1.433 0 0.148
Prepaid Expenses 8.72 4.704 0.888 0.382
Total Assets 605.905 487.175 116.702 44.231
Property/Plant/Equipment, Total - Net 21.307 20.686 22.083 2.242
Property/Plant/Equipment, Total - Gross 25.223 22.833 23.132 2.466
Accumulated Depreciation, Total -3.916 -2.147 -1.049 -0.224
Other Long Term Assets, Total 8.138 1.619 1.774 0.199
Total Current Liabilities 92.542 110.617 34.57 4.687
Accounts Payable 4.005 4.368 3.276 2.056
Accrued Expenses 25.08 12.896 7.175 2.225
Notes Payable/Short Term Debt 0 0 0 0
Current Port. of LT Debt/Capital Leases 1.138 0.689 0.681 0.302
Other Current Liabilities, Total 62.319 92.664 23.438 0.104
Total Liabilities 146.267 203.287 82.028 5.238
Total Long Term Debt 1.14 0.604 1.165 0.393
Capital Lease Obligations 1.14 0.604 1.165 0.393
Other Liabilities, Total 52.585 92.066 46.293 0.158
Total Equity 459.638 283.888 34.674 38.993
Redeemable Preferred Stock 109.08 73.429
Common Stock 0.005 0.004 0 0
Additional Paid-In Capital 689.275 412.777 2.044 0.774
Retained Earnings (Accumulated Deficit) -228.982 -128.765 -76.456 -35.21
Other Equity, Total -0.66 -0.128 0.006 0
Total Liabilities & Shareholders’ Equity 605.905 487.175 116.702 44.231
Total Common Shares Outstanding 51.5362 44.4822 43.1386 43.1386
Accounts Receivable - Trade, Net 0.135 0.856
Long Term Investments 125.187 162.531
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流动资产总额 431.382 451.273 543.731 364.806 340.791
现金和短期投资 420.812 442.418 536.386 359.107 333.537
现金等价物 33.733 47.976 156.819 84.903 53.098
短期投资 387.079 394.442 379.567 274.204 280.439
应收账款总额,净额 1.263 0.135 1.573 0.904 1.734
Accounts Receivable - Trade, Net 1.263 0.135 1.573 0.904 0.878
Prepaid Expenses 9.307 8.72 5.772 4.795 5.52
Total Assets 563.06 605.905 642.453 434.386 464.552
Property/Plant/Equipment, Total - Net 21.066 21.307 21.724 21.766 20.502
Property/Plant/Equipment, Total - Gross 25.668 25.223 24.951 24.942 23.127
Accumulated Depreciation, Total -4.602 -3.916 -3.227 -3.176 -2.625
Long Term Investments 102.478 125.187 74.692 45.305 101.639
Other Long Term Assets, Total 8.134 8.138 2.306 2.509 1.62
Total Current Liabilities 88.339 92.542 94.493 108.685 110.137
Accounts Payable 2.567 4.005 5.033 8.177 8.348
Accrued Expenses 22.913 25.08 21.105 16.838 12.962
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 1.087 1.138 1.189 1.038 0.64
Other Current Liabilities, Total 61.772 62.319 67.166 82.632 88.187
Total Liabilities 134.34 146.267 159.318 176.282 189.305
Total Long Term Debt 0.927 1.14 1.347 1.145 0.498
Capital Lease Obligations 0.927 1.14 1.347 1.145 0.498
Other Liabilities, Total 45.074 52.585 63.478 66.452 78.67
Total Equity 428.72 459.638 483.135 258.104 275.247
Common Stock 0.005 0.005 0.005 0.005 0.004
Additional Paid-In Capital 697.597 689.275 678.358 424.599 417.096
Retained Earnings (Accumulated Deficit) -265.666 -228.982 -195.082 -166.5 -141.84
Other Equity, Total -3.216 -0.66 -0.146 0 -0.013
Total Liabilities & Shareholders’ Equity 563.06 605.905 642.453 434.386 464.552
Total Common Shares Outstanding 51.6927 51.5362 51.2565 45.3277 44.8794
  • 年度
  • 每季度
2021 2020 2019 2018
净收入/起跑线 -100.217 -45.593 -41.246 -21.467
经营活动产生的现金 -128.946 88.13 17.905 -17.863
经营活动产生的现金 2.397 1.763 0.825 0.205
非现金物品 30.797 7.093 1.639 1.091
已付现金利息 0.158 0.115 0.046 0.015
营运资金的变化 -61.923 124.867 56.687 2.308
投资活动产生的现金 -99.835 -422.588 -16.486 -1.356
资本支出 -1.597 -9.096 -0.532 -1.356
其他投资现金流量项目,总计 -98.238 -413.492 -15.954 0
融资活动产生的现金 250.28 289.262 34.911 52.932
股票的发行(报废),净额 249.18 276.289 35.282 53.227
债务的发行(退还),净额 -0.849 -0.554 -0.371 -0.295
现金净变化 21.499 -45.196 36.33 33.713
融资现金流项目 1.949 13.527
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -36.684 -100.217 -66.317 -37.735 -13.075
Cash From Operating Activities -40.295 -128.946 -90.594 -53.334 -22.823
Cash From Operating Activities 0.687 2.397 1.708 1.037 0.485
Non-Cash Items 9.048 30.797 20.483 11.409 4.451
Cash Interest Paid 0.046 0.158 0.106 0.054 0.024
Changes in Working Capital -13.346 -61.923 -46.468 -28.045 -14.684
Cash From Investing Activities 25.863 -99.835 -31.816 105.046 44.323
Capital Expenditures -0.482 -1.597 -1.096 -0.79 -0.164
Other Investing Cash Flow Items, Total 26.345 -98.238 -30.72 105.836 44.487
Cash From Financing Activities 0.185 250.28 248.226 2.187 0.595
Financing Cash Flow Items 0 1.949 1.95 -0.397 -0.397
Issuance (Retirement) of Stock, Net 0.449 249.18 246.969 2.925 1.147
Issuance (Retirement) of Debt, Net -0.264 -0.849 -0.693 -0.341 -0.155
Net Change in Cash -14.247 21.499 125.816 53.899 22.095
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
Atlas Venture Venture Capital 10.6159 5858262 -126474 2023-01-12 LOW
BVF Partners L.P. Hedge Fund 8.5779 4733611 41007 2023-01-12 LOW
Wellington Management Company, LLP Investment Advisor/Hedge Fund 8.3197 4591089 1180703 2022-12-31 LOW
T. Rowe Price Associates, Inc. Investment Advisor 7.8899 4353945 277562 2022-12-31 LOW
Avoro Capital Advisors LLC Investment Advisor/Hedge Fund 6.9767 3850000 1680770 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 6.619 3652608 797130 2022-12-31 LOW
Vertex Pharmaceuticals Inc Corporation 5.8007 3201049 49928 2022-03-31
Baker Bros. Advisors LP Hedge Fund 5.2186 2879825 0 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 5.1577 2846221 160817 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 5.1454 2839421 172415 2022-12-31 LOW
Redmile Group, LLC Investment Advisor/Hedge Fund 4.8453 2673837 -202800 2022-12-31 LOW
Invus Public Equities Advisors, LLC Investment Advisor 3.6243 2000000 500000 2022-12-31 LOW
T. Rowe Price Investment Management, Inc. Investment Advisor 3.5445 1955977 -40552 2022-12-31 MED
Rock Springs Capital Management LP Hedge Fund 2.2249 1227779 181036 2022-12-31 LOW
Fidelity Management & Research Company LLC Investment Advisor 1.5331 846046 520360 2022-12-31 LOW
Wasatch Global Investors Inc Investment Advisor/Hedge Fund 1.5081 832221 -228340 2022-12-31 LOW
EcoR1 Capital, LLC Hedge Fund 1.4426 796093 0 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.3538 747071 45849 2022-12-31 LOW
Mellon Investments Corporation Investment Advisor/Hedge Fund 1.2316 679621 -41254 2022-12-31 LOW
Aquilo Capital Management, LLC Investment Advisor/Hedge Fund 1.1406 629411 299165 2022-12-31 LOW

为什么选择 Capital.com?让我们的数字来说话。

Capital.com Group

500K+

交易者

92K+

每月活跃客户

$53M+

每月投资额

$30M+

每月提取金额

交易計算器

如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。

貿易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模(槓桿 x 投資):
開倉

平倉

做空 做多

Kymera Therapeutics, Inc. Company profile

关于 Kymera Therapeutics Inc.

Kymera Therapeutics, Inc.是一家生物制药公司。 公司专注于发现和开发小分子疗法,通过利用人体自身的天然蛋白质降解系统选择性地降解致病蛋白质。 其靶向蛋白降解(TPD)平台Pegasus,使其能够发现对整个身体的致病蛋白具有活性的选择性小分子蛋白降解剂。 公司的Pegasus平台包括E3配体酶全身图谱、E3配体酶粘合剂工具箱、三元复合体模型、定量系统药理学模型和化学。 其临床阶段的项目包括IRAK4、IRAKIMiD和STAT3,它们分别针对白细胞介素-1受体/棒状受体(IL-1R/TLR)和贾努斯激酶/信号转导者和转录激活者(JAK/STAT)中的目标。 其项目重点是治疗一系列免疫炎症性疾病、血液学恶性肿瘤和实体瘤。

Industry: Biotechnology & Medical Research (NEC)

200 Arsenal Yards Blvd., Suite 230
2Nd Floor
WATERTOWN
MASSACHUSETTS 02472
US

收入报表

  • Annual
  • Quarterly

人们也观看

Oil - Crude

69.44 Price
+2.310% 1D Chg, %
多头隔夜费 -0.0194%
空头隔夜费 -0.0026%
隔夜费时间 21:00 (UTC)
价差 0.03

BTC/USD

28,106.50 Price
+0.010% 1D Chg, %
多头隔夜费 -0.0616%
空头隔夜费 0.0137%
隔夜费时间 21:00 (UTC)
价差 66.00

XRP/USD

0.46 Price
+21.930% 1D Chg, %
多头隔夜费 -0.0753%
空头隔夜费 0.0069%
隔夜费时间 21:00 (UTC)
价差 0.00446

US100

12,735.20 Price
+1.320% 1D Chg, %
多头隔夜费 -0.0241%
空头隔夜费 0.0018%
隔夜费时间 21:00 (UTC)
价差 1.8

还在找一位您可以信任的经纪商吗?

加入成为全球500,000万多名交易者的一份子,选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易